BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Pleyer L, Valent P, Greil R. Mesenchymal Stem and Progenitor Cells in Normal and Dysplastic Hematopoiesis-Masters of Survival and Clonality? Int J Mol Sci 2016;17:E1009. [PMID: 27355944 DOI: 10.3390/ijms17071009] [Cited by in Crossref: 26] [Cited by in F6Publishing: 21] [Article Influence: 4.3] [Reference Citation Analysis]
Number Citing Articles
1 Mattiucci D, Maurizi G, Leoni P, Poloni A. Aging- and Senescence-associated Changes of Mesenchymal Stromal Cells in Myelodysplastic Syndromes. Cell Transplant 2018;27:754-64. [PMID: 29682980 DOI: 10.1177/0963689717745890] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 3.3] [Reference Citation Analysis]
2 Medyouf H. The microenvironment in human myeloid malignancies: emerging concepts and therapeutic implications. Blood 2017;129:1617-26. [PMID: 28159735 DOI: 10.1182/blood-2016-11-696070] [Cited by in Crossref: 70] [Cited by in F6Publishing: 68] [Article Influence: 14.0] [Reference Citation Analysis]
3 Jacamo R, Davis RE, Ling X, Sonnylal S, Wang Z, Ma W, Zhang M, Ruvolo P, Ruvolo V, Wang RY, McQueen T, Lowe S, Zuber J, Kornblau SM, Konopleva M, Andreeff M. Tumor Trp53 status and genotype affect the bone marrow microenvironment in acute myeloid leukemia. Oncotarget 2017;8:83354-69. [PMID: 29137349 DOI: 10.18632/oncotarget.19042] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
4 Bauer M, Vaxevanis C, Al-Ali HK, Jaekel N, Naumann CLH, Schaffrath J, Rau A, Seliger B, Wickenhauser C. Altered Spatial Composition of the Immune Cell Repertoire in Association to CD34+ Blasts in Myelodysplastic Syndromes and Secondary Acute Myeloid Leukemia. Cancers (Basel) 2021;13:E186. [PMID: 33430322 DOI: 10.3390/cancers13020186] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
5 Banerjee T, Calvi LM, Becker MW, Liesveld JL. Flaming and fanning: The Spectrum of inflammatory influences in myelodysplastic syndromes. Blood Rev 2019;36:57-69. [PMID: 31036385 DOI: 10.1016/j.blre.2019.04.004] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
6 Li W, Li M, Wang H, Peng Y, Dong S, Lu Y, Wang F, Xu F, Liu L, Zhao Q. Infiltrating Immune Cells in Gastric Cancer: A Novel Predicting Model for Prognosis. J Cancer 2021;12:965-75. [PMID: 33442396 DOI: 10.7150/jca.51079] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
7 Ibraheem A, Attar-Schneider O, Dabbah M, Dolberg Jarchowsky O, Tartakover Matalon S, Lishner M, Drucker L. BM-MSCs-derived ECM modifies multiple myeloma phenotype and drug response in a source-dependent manner. Transl Res 2019;207:83-95. [PMID: 30738861 DOI: 10.1016/j.trsl.2019.01.003] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
8 Markovic N, Lukovic A, Arsenijevic N, Ninkovic S, Ljujic B. The Role of Tumor Microenvironment and Impact of Cancer Stem Cells on Breast Cancer Progression and Growth. Serbian Journal of Experimental and Clinical Research 2018;0:000010247820180018. [DOI: 10.2478/sjecr-2018-0018] [Reference Citation Analysis]
9 Ahamad N, Sun Y, Nascimento Da Conceicao V, Xavier Paul Ezhilan CRD, Natarajan M, Singh BB. Differential activation of Ca2+ influx channels modulate stem cell potency, their proliferation/viability and tissue regeneration. NPJ Regen Med 2021;6:67. [PMID: 34671058 DOI: 10.1038/s41536-021-00180-w] [Reference Citation Analysis]
10 Leisch M, Greil R, Pleyer L. IDO in MDS/AML disease progression and its role in resistance to azacitidine: a potential new drug target? Br J Haematol 2020;190:314-7. [PMID: 32419137 DOI: 10.1111/bjh.16710] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
11 Ayhan S, Nemutlu E, Uçkan Çetinkaya D, Kır S, Özgül RK. Characterization of human bone marrow niches with metabolome and transcriptome profiling. J Cell Sci 2021;134:jcs250720. [PMID: 33526717 DOI: 10.1242/jcs.250720] [Reference Citation Analysis]
12 Chen X, Li N, Weng J, Du X. Senescent Mesenchymal Stem Cells in Myelodysplastic Syndrome: Functional Alterations, Molecular Mechanisms, and Therapeutic Strategies. Front Cell Dev Biol 2020;8:617466. [PMID: 33644035 DOI: 10.3389/fcell.2020.617466] [Reference Citation Analysis]
13 Fattizzo B, Giannotta JA, Barcellini W. Mesenchymal Stem Cells in Aplastic Anemia and Myelodysplastic Syndromes: The "Seed and Soil" Crosstalk. Int J Mol Sci 2020;21:E5438. [PMID: 32751628 DOI: 10.3390/ijms21155438] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
14 Ahamad N, Singh BB. Calcium channels and their role in regenerative medicine. World J Stem Cells 2021; 13(4): 260-280 [PMID: 33959218 DOI: 10.4252/wjsc.v13.i4.260] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
15 Aanei CM, Catafal LC. Evaluation of bone marrow microenvironment could change how myelodysplastic syndromes are diagnosed and treated. Cytometry A 2018;93:916-28. [PMID: 30211968 DOI: 10.1002/cyto.a.23506] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
16 Fracchiolla NS, Fattizzo B, Cortelezzi A. Mesenchymal Stem Cells in Myeloid Malignancies: A Focus on Immune Escaping and Therapeutic Implications. Stem Cells Int 2017;2017:6720594. [PMID: 28947904 DOI: 10.1155/2017/6720594] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
17 Ahamad N, Sun Y, Singh BB. Increasing cytosolic Ca2+ levels restore cell proliferation and stem cell potency in aged MSCs. Stem Cell Res 2021;56:102560. [PMID: 34624617 DOI: 10.1016/j.scr.2021.102560] [Reference Citation Analysis]
18 Greil R, Hutterer E, Hartmann TN, Pleyer L. Reactivation of dormant anti-tumor immunity - a clinical perspective of therapeutic immune checkpoint modulation. Cell Commun Signal 2017;15:5. [PMID: 28100240 DOI: 10.1186/s12964-016-0155-9] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 4.8] [Reference Citation Analysis]
19 Pang Y, Geng S, Zhang H, Lai P, Liao P, Zeng L, Lu Z, Weng J, Du X. Phenotype of mesenchymal stem cells from patients with myelodyplastic syndrome maybe partly modulated by decitabine. Oncol Lett 2019;18:4457-66. [PMID: 31611955 DOI: 10.3892/ol.2019.10788] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
20 Kitagawa M, Kurata M, Onishi I, Yamamoto K. Bone marrow niches in myeloid neoplasms. Pathol Int 2020;70:63-71. [PMID: 31709722 DOI: 10.1111/pin.12870] [Reference Citation Analysis]
21 Bouchla A, Thomopoulos TP, Papageorgiou SG, Apostolopoulou C, Loucari C, Mpazani E, Pappa V. Predicting outcome in higher-risk myelodysplastic syndrome patients treated with azacitidine. Epigenomics 2021;13:1129-43. [PMID: 34291653 DOI: 10.2217/epi-2021-0124] [Reference Citation Analysis]
22 Anand BG, Prajapati KP, Dubey K, Ahamad N, Shekhawat DS, Rath PC, Joseph GK, Kar K. Self-Assembly of Artificial Sweetener Aspartame Yields Amyloid-like Cytotoxic Nanostructures. ACS Nano 2019;13:6033-49. [PMID: 31021591 DOI: 10.1021/acsnano.9b02284] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 4.3] [Reference Citation Analysis]
23 Ahamad N, Rath PC. Expression of interferon regulatory factors (IRF-1 and IRF-2) during radiation-induced damage and regeneration of bone marrow by transplantation in mouse. Mol Biol Rep. 2019;46:551-567. [PMID: 30488374 DOI: 10.1007/s11033-018-4508-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]